Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5705343 | Ophthalmology | 2017 | 11 Pages |
Abstract
Polymerase chain reaction testing of ocular fluid is useful in supporting a clinical diagnosis of ARN, but treatment should not be delayed while awaiting PCR results. Initial oral or intravenous antiviral therapy is effective in treating ARN. The adjunctive use of intravitreal foscarnet may be more effective than systemic therapy alone. The role of prophylactic laser retinopexy or early PPV is unknown at this time.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Scott D. MD, Stephen J. MD, Jennifer E. MD, PhD, Prithvi MD, Steven MD, Sophie J. MD, Justis P. MD,